Year None 2026 2025 2024 2023 2022 2021 2020 2019 Oct 21, 2026 Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026 Oct 09, 2026 Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV a Oct 06, 2026 Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award Oct 02, 2026 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sep 29, 2026 Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of S Sep 04, 2026 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sep 02, 2026 Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference Aug 07, 2026 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 05, 2026 Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last » Displaying 1 - 9 of 38